Big Pharma spends big lobbying bucks; U.S. DoJ probes bile-duct stent market;

> They say you get what you pay for--so why not go for broke where lobbying is concerned? Perhaps that's what four Big Pharma companies were thinking when they spent some serious cash to lobby congress in the second quarter of 2008. FiercePharma

> The U.S. Department of Justice has launched a probe of the bile-duct stent market, trying to determine whether companies such as Abbott Laboratories, Boston Scientific and Johnson & Johnson improperly promoted the devices. FiercePharma

> Injecting a large dose of vitamin C into mice started a chain reaction that destroyed cancer cells in mice, according to a research team at the National Institutes of Health. FierceVaccines

> In a new, experimental procedure, surgeons are testing implantable lenses to help children with lazy eye avoid deterioration of their vision. Article

And Finally... Dude, we know you're aggravated. But if you smash the house, nobody will pay rent on it. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.